News
News
Outcome Capital Continues to Expand with the Addition of Charles Simmons
Appointment of Charles Simmons as Managing Director continues to strengthen Outcome’s capabilities
Read MoreResources
Outcome Capital Life Science Market Pulse, November 2024
Outcome Capital Life Science Market Pulse November 2024 Click to view our LifeSciences Pulse Newsletter
DownloadNews
Outcome Capital Announces ATPCO Has Acquired Routehappy
Outcome Capital Announces ATPCO Has Acquired Routehappy February 26, 2018, Reston, VA and Boston, MA. Outcome Capital, an investment banking firm that serves middle market...
Read MoreNews
36th Annual JP Morgan Healthcare Conference
Outcome Capital looks forward to attending JP Morgan’s Annual Healthcare Conference in January 2018. If you are interested in meeting to discuss your...
Read MoreNews
Licensing Executives Society 2017 Annual Meeting
Plenary Session: Different Approaches VCs Take When Investing in Companies Tuesday, October 24th 2:30 PM – 3:30 PM Location: Grand Ballroom—Salons 1 & 2 (7th...
Read MoreNews
Slone Partners Networking Event
Building an Amazing Organization with the Strength of the Right Financial Partners Oded Ben-Joseph, PhD. from Outcome Capital is pleased to take part as...
Read MoreNews
Outcome Capital and Boston University’s BEST Program Partner to Give Scientists Real-Life Experience in the Life Science Sector
Outcome Capital and Boston University’s BEST Program Partner to Give Scientists Real-Life Experience in the Life Science Sector June 21, 2017, Boston, MA. Outcome Capital,...
Read MoreNews
UCB Pharma Acquires Beryllium Discovery
Outcome Capital Announces UCB Pharma Has Acquired Beryllium Discovery June 6, 2017, Boston, MA. Outcome Capital, an investment banking firm that serves middle market growth...
Read MoreNews
Outcome Capital Congratulates ColonaryConcepts on Sale
Outcome Capital Congratulates ColonaryConcepts on Sale of Colon Preparation Business Unit to Sebela Pharmaceuticals June 1, 2017, Boston, MA. Outcome Capital (outcomecapital.wpengine.com), a highly specialized investment...
Read MoreNews
Outcome Capital Expands Biotech Practice With Hire of Dr. Ellen S. Baron
Dr. Baron’s Extensive Life Science Investment Experience and Deep Knowledge of Emerging Growth Pharma and Biotech Markets Will Bolster Outcome’s Client Service Offerings January 24,...
Read MoreNews
Outcome Capital and Sawyer Business School Partner to Give Students Real-Life Experience in the Life Sciences and Technology Sectors
December 07, 2016, Boston, MA. Outcome Capital, LLC today announced a collaboration with Suffolk University’s Sawyer Business School aimed at providing graduate-level students with real-world...
Read MoreNews
Outcome Capital Expands to Europe With New UK Operations
Shawn Manning Appointed Managing Director of London Office September 28, 2016, Boston, MA, USA & London, UK. Outcome Capital, LLC (outcomecapital.wpengine.com), an investment banking firm...
Read MoreNews
Outcome Capital Moves to New Boston Office
September 23, 2016 , Boston, MA. Outcome Capital (outcomecapital.wpengine.com), an investment banking firm that serves middle-market growth companies in life sciences and technology markets, today...
Read MoreNews
Dr. Oded Ben-Joseph’s “Where the Bodies Lie” Article Published
Dr. Oded Ben-Joseph, Managing Director, has recently published an article in Nature Biotechnology’s August 2016 issue, “Where the Bodies Lie,” about avoiding common mistakes made...
Read MoreNews
Intelligent Decisions Sells Two Business Units to Federal Data Systems
Intelligent Decisions, a developer of innovative IT solutions for the Federal Government May, 2016, Outcome Capital is pleased to announce that Intelligent Decisions, a developer of...
Read MoreNews
Sun Capital Acquires Smart Grid Solutions – Division of Apex CoVantage
Developer of ProField®, the award-winning mobile workforce management technology used for Smart Metering deployments April 23, 2016, Outcome Capital is pleased to announce that Sun...
Read MoreNews
Active VCs vs. Zombies: Dysfunctional Boards That Mess With M&A
Article By Luke Timmerman / February 22, 2016 Investors want to know: Will Big Pharma go bargain hunting, do a little M&A? Will it lift...
Read MoreNews
Outcome Capital Announces Biosense Webster, Inc. Has Acquired Coherex Medical
Transaction Allows Access to Unique Coherex WaveCrest® Left Atrial Appendage Occlusion System for Stroke Prevention in High-Risk Patients November 20, 2015, Wellesley, MA & Reston, VA....
Read MoreNews
Outcome Capital Adds Donald D. Haut to Growing Life Sciences Practice
Seasoned Industry Advisor Brings Deep Domain Expertise and Operational Experience October 15, 2015, Wellesley, MA and Reston, VA Outcome Capital (outcomecapital.wpengine.com), an investment banking firm...
Read MoreNews
Outcome Capital Expands Its Life Sciences Practice With the Addition of Craig Steger
July 20, 2015, Wellesley, MA. & Reston, VA. Outcome Capital (outcomecapital.wpengine.com) today announced that Craig A. Steger has joined the firm as a Senior Advisor...
Read MoreNews
Medtronic Acquires Advanced Uro-Solutions
NURO Percutaneous Tibial Nerve Stimulation System to Enhance Neuromodulation Product Offerings for Treatment of Bladder Control Issues February 25, 2015, Outcome Capital is pleased to...
Read MoreNews
DNAe Acquires nanoMR Inc. in a Strategic Move to Own Complete Workflow for Point-Of-Need NGS-Based Blood-To-Result Diagnostic
Acquisition enables immediate presence in USA, a key market for bloodstream infection diagnosis and other applications January 19, 2015, London, UK and Albuquerque, NM, USA...
Read MoreContact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2024. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Business Continuity Plan | Privacy Policy | Regulation Best Interest
